Lesley Ann Calhoun is a director of Tango Therapeutics Inc.
Person profile
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Aligos Therapeutics, Inc.
4 Mar 24
4
Aligos Therapeutics, Inc.
28 Feb 24
4
Aligos Therapeutics, Inc.
12 Sep 23
4
Tango Therapeutics, Inc.
8 Jun 23
4
Aligos Therapeutics, Inc.
17 Mar 23
4
Aligos Therapeutics, Inc.
11 Jul 22
4
Tango Therapeutics, Inc.
28 Jun 22
4
Aligos Therapeutics, Inc.
8 Feb 22
3
Tango Therapeutics, Inc.
12 Aug 21
4
Aligos Therapeutics, Inc.
3 Dec 20
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
1 Mar 24 | ALGS Aligos Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 1.13 | 308,940 | 349.10 k | 308,940 |
28 Feb 24 | ALGS Aligos Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 0.96 | 18,750 | 18.00 k | 18,750 |
28 Feb 24 | ALGS Aligos Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 0.96 | 74,998 | 72.00 k | 74,998 |
28 Feb 24 | ALGS Aligos Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 0.96 | 51,833 | 49.76 k | 51,833 |
27 Feb 24 | ALGS Aligos Therapeutics | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 3.06 | 26,250 | 80.33 k | 0 |
27 Feb 24 | ALGS Aligos Therapeutics | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 3.06 | 105,000 | 321.30 k | 0 |
27 Feb 24 | ALGS Aligos Therapeutics | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 16.18 | 176,237 | 2.85 mm | 0 |
8 Sep 23 | ALGS Aligos Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 0.84 | 48,000 | 40.32 k | 48,000 |
6 Jun 23 | TNGX Tango Therapeutics | Common Stock | Grant | Acquire A | No | No | 0 | 5,000 | 0.00 | 5,000 |
6 Jun 23 | TNGX Tango Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 3.55 | 30,000 | 106.50 k | 30,000 |